Assessing the association between leptin and bone mineral density in HIV-infected men

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Rao, Madhu N ^a,b   Schambelan, Morris ^a,b   Tai, Viva W ^b   Abrams, Donald I ^a,b   Khatami, Hootan ^c   Havel, Peter J ^d   Sakkas, Giorgos ^e   Mulligan, Kathleen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c DAIICHI SANKYO INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873831521     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/103072     Document Type: Article

References (22)

1. Brown T. T., Qaqish R. B., Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006 20 17 2165 2174 2-s2.0-33750591177 10.1097/QAD.0b013e32801022eb (Pubitemid 44684707)
2. McComsey G. A., Tebas P., Shane E., Yin M. T., Overton E. T., Huang J. S., Aldrovandi G. M., Cardoso S. W., Santana J. L., Brown T. T., Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clinical Infectious Diseases 2010 51 8 937 946 2-s2.0-77957855493 10.1086/656412
3. Rosenthall L., Falutz J., Bone mineral and soft-tissue changes in AIDS-associated lipoatrophy. Journal of Bone and Mineral Metabolism 2005 23 1 53 57 2-s2.0-12444286800 10.1007/s00774-004-0541-z
4. Aukrust P., Haug C. J., Ueland T., Lien E., Müller F., Espevik T., Bollerslev J., Frøland S. S., Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone- remodeling process during highly active antiretroviral therapy. Journal of Clinical Endocrinology and Metabolism 1999 84 1 145 150 2-s2.0-0032901916 10.1210/jc.84.1.145 (Pubitemid 29036693)
5. Karsenty G., Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metabolism 2006 4 5 341 348 2-s2.0-33750453786 10.1016/j.cmet.2006.10.008 (Pubitemid 44645074)
6. Thomas T., Burguera B., Melton L. J., Atkinson E. J., O'Fallon W. M., Riggs B. L., Khosla S., Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 2001 29 2 114 120 2-s2.0-0034896519 10.1016/S8756-3282(01)00487-2 (Pubitemid 32734491)
7. Weiss L. A., Barrett-Connor E., Von Mühlen D., Clark P., Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo Study. Journal of Bone and Mineral Research 2006 21 5 758 764 2-s2.0-33646237558 10.1359/jbmr.060206
8. Blain H., Vuillemin A., Guillemin F., Durant R., Hanesse B., De Talance N., Doucet B., Jeandel C., Serum leptin level is a predictor of bone mineral density in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2002 87 3 1030 1035 2-s2.0-0036964277 10.1210/jc.87.3.1030 (Pubitemid 36121060)
9. Sato M., Takeda N., Sarui H., Takami R., Takami K., Hayashi M., Sasaki A., Kawachi S., Yoshino K., Yasuda K., Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. Journal of Clinical Endocrinology and Metabolism 2001 86 11 5273 5276 2-s2.0-17944366046 10.1210/jc.86.11.5273 (Pubitemid 33070248)
10. Ducy P., Amling M., Takeda S., Priemel M., Schilling A. F., Beil F. T., Shen J., Vinson C., Rueger J. M., Karsenty G., Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000 100 2 197 207 2-s2.0-0141737573 (Pubitemid 30064908)
11. Montague C. T., Prins J. B., Sanders L., Digby J. E., O'Rahilly S., Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997 46 3 342 347 2-s2.0-0031054698 (Pubitemid 27090260)
12. Nagy T. R., Gower B. A., Trowbridge C. A., Dezenberg C., Shewchuk R. M., Goran M. I., Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children. Journal of Clinical Endocrinology and Metabolism 1997 82 7 2148 2152 2-s2.0-0030754054 10.1210/jc.82.7.2148 (Pubitemid 27287575)
13. Grinspoon S., Carr A., Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine 2005 352 1 48 62 2-s2.0-11344293751 10.1056/NEJMra041811 (Pubitemid 40075680)
14. Gallant J. E., Staszewski S., Pozniak A. L., DeJesus E., Suleiman J. M. A. H., Miller M. D., Coakley D. F., Lu B., Toole J. J., Cheng A. K., Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. Journal of the American Medical Association 2004 292 2 191 201 2-s2.0-3042848853 10.1001/jama.292.2.191 (Pubitemid 38917996)
15. Mulligan K., Tai V. W., Algren H., Abrams D. I., Leiser R. J., Lo J. C., Schambelan M., Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy. Journal of Acquired Immune Deficiency Syndromes 2001 26 5 443 448 2-s2.0-0035870550 (Pubitemid 32489022)
16. Sakkas G. K., Mulligan K., Dasilva M., Doyle J. W., Khatami H., Schleich T., Kent-Braun J. A., Schambelan M., Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study. PLoS ONE 2009 4 2 e4605 2-s2.0-65349167904 10.1371/journal.pone.0004605
17. Abrams D. I., Hilton J. F., Leiser R. J., Shade S. B., Elbeik T. A., Aweeka F. T., Benowitz N. L., Bredt B. M., Kosel B., Aberg J. A., Deeks S. G., Mitchell T. F., Mulligan K., Bacchetti P., McCune J. M., Schambelan M., Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, Placebo-controlled clinical trial. Annals of Internal Medicine 2003 139 4 258 I44 2-s2.0-0141677644
18. Lo J. C., Mulligan K., Noor M. A., Schwarz J. M., Halvorsen R. A., Grunfeld C., Schambelan M., The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. Journal of Clinical Endocrinology and Metabolism 2001 86 8 3480 3487 2-s2.0-0034886796 10.1210/jc.86.8.3480 (Pubitemid 32761682)
19. Lo J. C., Mulligan K., Tai V. W., Algren H., Schambelan M., 'Buffalo hump' in men with HIV-1 infection. The Lancet 1998 351 9106 867 870 2-s2.0-0032554569 10.1016/S0140-6736(97)11443-X (Pubitemid 28121175)
20. Faraj M., Havel P. J., Phélis S., Blank D., Sniderman A. D., Cianflone K., Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 4 1594 1602 2-s2.0-0038439261 10.1210/jc.2002-021309 (Pubitemid 36623375)
21. Martínez E., Larrousse M., Podzamczer D., Gatell J. M., Objective amount of limb fat in HIV-infected subjects with subjective diagnosis of lipoatrophy. HIV Medicine 2009 10 4 257 261 2-s2.0-62749151025 10.1111/j.1468-1293.2008.00680.x
22. Madeddu G., Spanu A., Chessa F., Calia G. M., Lovigu C., Mannazzu M., Falchi A., Sanna D., Mura M. S., Madeddu G., Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009 53 3 290 301 2-s2.0-70349572795